These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [The pathological/MR tomographic correlation and differential diagnosis of malignant kidney tumors].
    Author: Kreft B, Flacke S, Conrad R, Pauleit D, Bachmann R, Wardelmann E, Albers P, Schild H.
    Journal: Rofo; 1999 Aug; 171(2):106-12. PubMed ID: 10506883.
    Abstract:
    PURPOSE: Evaluation of malignancy criteria in MRT of kidney tumors in correlation with the histopathological findings. MATERIALS AND METHODS: 41 patients with suspected malignant kidney tumors were examined using a T1 SE sequence (TR/TE 300/10 ms) before and after i.v. administration of 0.1 mmol/kg Gd-DTPA and a T2 SE sequence (TR/TE 5500/150 ms). The results were correlated with the pathological findings. RESULTS: 38 malignant tumors were found: 29 renal cell carcinomas (RCC), 13 with solid growth, 11 with tubulopapillary growth, and three with mixed growth forms, one cystic RCC, and one chromophobic RCC, in addition, 6 urothelial carcinomas and three other malignomas. Typical MRT criteria for RCC were an inhomogeneity of the tumor with regions of slightly increased signal intensity on the T1-weighted image (59%) and regions with reduced signal intensity on the T2-weighted image (96%) as compared with renal parenchyma; these were due to histomorphological hemorrhage and hemosiderin deposits, respectively. A further criterion for RCC was a hypointense pseudocapsule in the T2 TSE sequence in 79% of the cases. CONCLUSIONS: The low-signal nature of RCC in the T2-weighted image correlates with hemorrhage and hemosiderin deposits. The detection of a pseudocapsule is useful in the differential diagnosis of solid tumors in the kidney.
    [Abstract] [Full Text] [Related] [New Search]